Technical Data
AGT (Angiotensinogen, Serpin A8, SERPINA8)
The human AGT gene product, pre-angiotensinogen, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product, angiotensin I is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. Human pre-angiotensinogen is encoded by two mRNAs that differ only in the length of the 3'-untranslated region due to postulated use of two polyadenylation sites. There may also be alternative initiation codons (nucleotides 40-42 and 67-69). AGT is involved in maintaining blood pressure and in the pathogenesis of essential hypertension and preeclampsia.

Suitable for use in ELISA, Western Blot and Immunohistochemistry. Other applications not tested.

Recommended Dilution:
Western Blot: 1:500-1:1000
Immunohistochemistry (Formalin fixed paraffin embedded): 5ug/ml
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
MabIgG3,k3C10Affinity Purified
50ug4C Do Not FreezeBlue IceHumanMouse
Recombinant corresponding to aa1-486 from human AGT with GST tag. MW of the GST tag alone is 26kD.
Purified by Protein A affinity chromatography.
Supplied as a liquid in PBS, pH 7.2.
Recognizes human AGT.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.